Dougé Aurore

  • postdoc; MD/PhD
  • +47 22 78 23 19

CHU Clermont-Ferrand

French League against cancer

Education:

* 2023: Inter-University Diploma in Medical Pedagogy, University of Rouen, France.

* 2022: PhD Diploma - Specialty in Health Biology - Defense on November 30, 2022, SVSAE Doctoral School, Clermont-Ferrand, France.

* 2019: Diploma of Doctor of Medicine – Specialty in Oncology, Option Oncohematology - Defense on July 05, 2019, UFR Medicine and Pharmacy, Clermont-Ferrand, France.

* 2018: Master's Degree II in Health Biology - Specialization in Genetics, Physiology, and Pathology, UFR Medicine and Pharmacy, Clermont-Ferrand, France.

 

Professional Experience:

* From 04 November 2024-present: postdoctoral researcher in Department of Cellular Therapy, Oslo University Hospital, Norway. Participation in the development of K101 CAR-T cell in solid tumors.

* Since January 1, 2024: Medical Coordinator of the Early-Phase Cancer and Cellular Therapy Unit, Estaing University Hospital, Clermont-Ferrand, France.

* Since November 2, 2023: Hospital Practitioner - Medical Oncology Department (Prof. BAY) – Gabriel Montpied University Hospital, Clermont-Ferrand, France.

* November 4, 2019, to November 1, 2022: Hospital Assistant – Medical Oncology Department (Prof. JO BAY), Clermont-Ferrand University Hospital, France.

* November 2019 to November 2022: PhD student. Research Project: "Controlled expression of a therapeutic gene in T lymphocytes for use in cellular immunotherapy", PROTEOSTASIS Team - UMR 1019 - Human Nutrition Unit - INRAe - Clermont-Ferrand, France.

 

Research interests/projects:

Development of CAR-T cells in solid tumors, cancer immunotherapy, GMP production of cell therapy.